Events

Title	Presenter Bio
"A Proteomics Approach to Understanding Protein Ubiquitination" by Junmin Peng, Harvard Medical School Junmin_peng@hms.harvard.edu	12/2000-present, Postdoctoral Research Fellow, Department of Cell Biology, Harvard Medical School, U.S.A. Proteome analysis using multidimensional liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Advisor: Dr. Steven P. Gygi. 8/1999-12/2000, Postdoctoral Research Fellow, Howard Hughes Medical Institute, Department of Pathology, Harvard Medical School, Boston, U.S.A. Exploring the role of Cdk5 in brain development as well as in the pathogenesis of neurodegenerative diseases. Advisor: Dr. Li- Huei Tsai. 8/1994-8/1999, Graduate Research Assistant, Department of Biochemistry, University of Iowa, Iowa City, U.S.A. Discovery of P-TEFb (CDK9/cyclin T), a kinase controlling transcription elongation and HIV transactivation. Advisor: Dr. David H. Price.
"ProteoSep: A Viable All-Liquid Phase Alternative To 2D Gels" by Timothy Barder, Eprogen tbarder@eprogen.com	Dr. Barder worked in numerous R&D and business development positions at Allied-Signal and UOP (currently Honeywell Corporation) from 1984 to 1994, focusing on the research, development and commercialization of novel separation systems and processes for use in pharmaceuticals, natural products and fine chemicals. Dr. Barder holds 11 patents with 5 pending. Dr. Barder co-founded MICRA( Scientific, Inc. in 1994, which was formed to commercialize two of his UOP inventions centering on a novel line of ultra-fast high performance liquid chromatography (HPLC) supports for use in the field of proteomics and high throughput analysis of complex mixtures. MICRA (Scientific, Inc. merged with Eichrom Industries, Inc. in 1998 to form Eichrom Technologies,Inc. , where he served as the Vice President of Research and Commercial Development. In this capacity, he expanded the product offerings and technology portfolio of the combined companies to include commercialization of food safety and cancer diagnostic IVD devices, as well as the development of the ProteoSep (technology. These products and technologies are now owned and serviced by Eprogen, where Dr. Barder is the Chief Scientific Officer. Dr. Barder received his B.S. in Chemistry from the College of St. Thomas (St. Paul, Minnesota) and a Ph.D. in Chemistry from Purdue University in 1984.
"Proteome Scale Purification of Human Proteins from Bacteria" by Pascal Braun, Harvard Medical School pascal_braun@hms.harvard.edu	1996 Diploma in Biochemistry from the Free University of Berlin 1997 - present Graduate Studies with Ed Harlow and Josh LabBaer at the MGH Cancer Center and Institute of Proteomics at Harvard Medical School.